Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-04

Clinical Trial Update: Study on Cefotaxime and Sulbactam Sodium for Injection (2:1) for Treatment of Respiratory and Urinary Tract Infection

View source ↗

Summary

Clinical trial update for cefotaxime and sulbactam sodium combination in respiratory and urinary tract infections; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefotaxime and sulbactam sodium for injection (2:1)

Snippet

Sponsor: Xiangbei Welman Pharmaceutical Co., Ltd | Conditions: Respiratory Tract Infections, Urinary Tract Infections | Status: COMPLETED | Results posted: 2019-10-04